Devant, Pascal
Kagan, Jonathan C. http://orcid.org/0000-0003-2364-2746
Article History
Received: 22 February 2023
Accepted: 3 May 2023
First Online: 5 June 2023
Competing interests
: J.C.K. consults and holds equity in Corner Therapeutics, Larkspur Biosciences and Neumora Therapeutics. None of these relationships influenced this study. The other authors declare no competing interests.
Free to read: This content has been made available to all.